This view was confirmed in a finding that subjects with obesity and DM had lower serum levels of FGF 19 and higher levels of bile acid clinically [29], which is consistent with the results of our current study. The gene discussed is FGF19; the disease is obesity due to melanocortin 4 receptor deficiency.